AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA replacement therapy for cancer, announced the presentation today of new preclinical data on the development of a miRNA-based therapeutic candidate for primary liver cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco, CA. The data were simultaneously presented at the 2011 CPRIT Innovations in Cancer Prevention and Research Conference in Austin, TX.
